{
    "patient": {
        "Name": "Tyler Mason",
        "DateOfBirth": "1982-05-02",
        "Sex": "Male",
        "Diagnosis": "Merkel cell carcinoma",
        "BodyPart": "Skin",
        "Physician": "Dr. Cheryl Santos",
        "TreatingInstitution": "Contreras LLC"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Skin",
            "CollectedDate": "2023-09-23",
            "ReceivedDate": "2023-09-23",
            "TumorPercentage": "33%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-09-24",
            "ReceivedDate": "2023-09-29"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "FLT3",
                "DNA Alteration": "c.2039C>T",
                "GeneMutation": "p.V592A Nonsense-LOF",
                "VariantAlleleFraction": "3.72%"
            },
            {
                "Gene": "HDAC1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.Y303H Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "12.51%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "PTEN",
                "DNA Alteration": "c.389G>C",
                "GeneMutation": "p.L182* Nonsense-LOF",
                "VariantAlleleFraction": "29.33%"
            },
            {
                "Gene": "FGFR4",
                "DNA Alteration": "c.1162G>A",
                "GeneMutation": "p.G388R Frameshift-LOF",
                "VariantAlleleFraction": "2.8%"
            },
            {
                "Gene": "PTPN11",
                "DNA Alteration": "c.1508G>C",
                "GeneMutation": "p.R130G Frameshift-GOF",
                "VariantAlleleFraction": "1.35%"
            },
            {
                "Gene": "MSH2",
                "DNA Alteration": "c.1906G>C",
                "GeneMutation": "p.R130Q Frameshift-LOF",
                "VariantAlleleFraction": "10.1%"
            },
            {
                "Gene": "MTOR",
                "DNA Alteration": "c.5664C>G",
                "GeneMutation": "p.R130P Nonsense-LOF",
                "VariantAlleleFraction": "5.02%"
            },
            {
                "Gene": "CTNNB1",
                "DNA Alteration": "c.121A>G",
                "GeneMutation": "p.S37F Spliceregionvariant-GOF",
                "VariantAlleleFraction": "1.29%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "MYCN",
            "PTCH1",
            "HSP90B1"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "43 m/Mb",
            "Tmbpercentile": "92%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Equivocal"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}